Skip to main content
Premium Trial:

Request an Annual Quote

PE Biosystems Ships 1,000th ABI Prism 3700, Appoints Smeltzer to VP Finance

Premium

FOSTER CITY, Calif.--PE Biosystems announced that, less than a year after shipping its first ABI Prism 3700 DNA Analyzer, it has shipped number 1,000.

The company said most of its production-scale systems are being used for whole-genome sequencing, but added that they are also being adopted for use in food safety, drug target discovery, DNA forensic typing, environmental analysis, and clinical diagnosis. More than 250 laboratories worldwide have installed the machines, the company claimed.

The US Department of Agriculture, which has already installed several of the machines at sites across the country, was PE's 1,000th customer. Floyd Horn, USDA's Agricultural Research Service administrator, said the instruments are enabling the agency to "make a quantum leap into genomics" and to heighten its efforts to ensure food supply safety.

PE Biosystems also announced that Deborah Smeltzer, 46, formerly chief scientific officer at genomics company Genset in Paris, took the position of vice-president for finance at PE Biosystems on November 15.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.